Post by Symeres

We all know the decisions in drug discovery that keep you up at night. Do you optimize for potency or synthetic accessibility? Push a borderline metabolic profile or pivot the scaffold? Commit to a formulation strategy before tox data comes back? These aren't technical problems with clean answers. They're trade-offs. In most programs, they're being made by one discipline at a time, without full visibility into what the choice means downstream. When disciplines work in parallel instead of sequence, you're better equipped to make those trade-offs: • Chemistry understands what development will need before locking in a route • ADME flags liabilities while there's still time to design around them • Biology and formulation teams talk early, not after candidate selection Integrated discovery and development doesn't eliminate hard choices. It just makes sure you're equipped to make them. 💬 How does your team balance competing priorities across discovery and development?